Low-Temperature Pre-activation Technology Introduction-1
What is Low-Temperature Pre-activation
In peptide synthesis, special amino acids such as histidine, cysteine, serine and threonine exhibit poor structural stability. Under room-temperature activation conditions, they are highly susceptible to racemization, producing optical isomer impurities. Such impurities have similar properties to target peptides and are extremely difficult to remove in downstream purification, representing a key bottleneck limiting the purity of high-end peptides.
Why Racemization is a Key Bottleneck
Low-temperature pre-activation technology significantly reduces molecular thermal motion and kinetically suppresses amino-acid racemization side-reactions. It maximally preserves the native chiral configuration of amino acids, greatly improves the optical purity and structural correctness of target products, and is well-suited for the production of high-purity API-grade peptides.
How the Technology Works
The synchronous-activation mode carried out inside the main reactor of conventional synthesizers suffers from inadequate material mixing, local overheating and incomplete activation. These defects readily cause incomplete coupling, peptide chain truncation and reduced yield. The independent low-temperature pre-activation system enables sufficient, gentle and homogeneous activation.
The resulting activated esters possess consistent activity and high stability. After being transferred into the main reactor, they rapidly and efficiently couple with peptide chains on resin, effectively improving coupling conversion rates, shortening overall synthesis cycles, and lowering the formation probability of process-related impurities such as truncated and defective peptides.
The pre-activation process is physically separated from the coupling process in the main reactor. Trace by-products and unreacted raw materials generated during pre-activation cannot contaminate the resin or the peptide-chain growth environment. Combined with dedicated pipeline flushing logic, cross-contamination between batches and between different amino acids is thoroughly eliminated. It ensures system cleanliness for each coupling cycle and substantially improves batch-to-batch consistency.
| Process Parameter | Conventional Synchronous Activation | Independent Low-Temperature Pre-Activation |
|---|---|---|
| Mixing & Temperature | Inadequate mixing, local overheating | Sufficient, gentle, and homogeneous activation |
| Activation & Coupling | Incomplete activation, higher truncation risk | Consistent activity, high stability, efficient coupling |
| Contamination Control | High risk of cross-contamination in main reactor | Physically separated, dedicated flushing logic |
Applicable Scenarios & Value
Low-temperature pre-activation technology is particularly applicable to the preparation of high-difficulty, high-purity and high-value-added peptide products.
Typical Application Cases
- Peptide sequences containing racemization prone amino acids such as histidine and cysteine
- Long-chain peptides (80-100 aa)
- Highly-hydrophobic peptides
- Peptides with complex steric hindrance
Target Product Categories
- Pharmaceutical peptide APIs
- GLP-1-related innovative peptides
- High-end vaccine antigen peptides
- Precision diagnostic antigen peptides
Industrial Value
From an industrial perspective, this technology addresses common industry pain points of conventional peptide synthesis: excessive racemic impurities, high purification costs, low qualified-product rates and poor batch stability. It markedly enhances the yield and qualification rate of high-end peptides, reduces downstream purification costs and production losses, and enables pharmaceutical enterprises and CDMOs to achieve stable, compliant and large-scale manufacturing of high-grade peptides. It provides solid technical support for the R&D, translation and industrialization of peptide drugs.